3.26
前日終値:
$3.17
開ける:
$3.17
24時間の取引高:
2.79M
Relative Volume:
1.46
時価総額:
$280.01M
収益:
-
当期純損益:
$-48.17M
株価収益率:
-5.7193
EPS:
-0.57
ネットキャッシュフロー:
$-37.10M
1週間 パフォーマンス:
-10.56%
1か月 パフォーマンス:
-65.13%
6か月 パフォーマンス:
-58.10%
1年 パフォーマンス:
-63.86%
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
名前
Anavex Life Sciences Corporation
セクター
電話
844-689-3939
住所
630 5TH AVENUE, NEW YORK
AVXL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
AVXL
Anavex Life Sciences Corporation
|
3.26 | 272.28M | 0 | -48.17M | -37.10M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-12-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-09-23 | 開始されました | BTIG Research | Buy |
| 2020-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-28 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-02-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-18 | 開始されました | Janney | Buy |
| 2018-05-16 | 再開されました | Maxim Group | Buy |
| 2018-03-08 | 開始されました | ROTH Capital | Buy |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
| 2017-09-29 | 再開されました | Noble Financial | Buy |
| 2017-02-07 | 開始されました | Noble Financial | Buy |
| 2016-03-29 | 開始されました | FBR Capital | Outperform |
すべてを表示
Anavex Life Sciences Corporation (AVXL) 最新ニュース
Will Anavex Life Sciences Corp. stock rally after Fed decisions2025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - newser.com
Can Anavex Life Sciences Corp. stock maintain operating marginsWeekly Trade Review & Detailed Earnings Play Alerts - newser.com
How Anavex Life Sciences Corp. (12X1) stock trades after rate cuts - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp.AVXL - cnhinews.com
Anavex Life Sciences Corp. to Release Fiscal Year End Financial Results on November 25, 2025 - Quiver Quantitative
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 - MarketScreener
Anavex Life Sciences (Nasdaq: AVXL) to Report Fiscal 2025 Results on Nov. 25 - Stock Titan
A significant driver of top-line growth: Anavex Life Sciences Corporation (AVXL) - Setenews
Can Anavex Life Sciences Corp. stock deliver strong Q4 earnings2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Is Anavex Life Sciences Corp. stock resilient to inflationWeekly Investment Recap & Entry Point Confirmation Alerts - newser.com
Will Anavex Life Sciences Corp. (12X1) stock rise with strong economyJuly 2025 Opening Moves & Pattern Based Trade Signal System - newser.com
How strong is Anavex Life Sciences Corp. stock revenue growthQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Will Anavex Life Sciences Corp. (12X1) stock deliver compounding returns2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
D. Boral Capital Maintains Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq
Can Anavex Life Sciences Corp. stock attract ESG capital inflowsM&A Rumor & Growth Oriented Trade Recommendations - newser.com
Anavex Life Sciences Corp. (AVXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Anavex Life Sciences (NASDAQ:AVXL) Reaches New 12-Month LowHere's Why - MarketBeat
Real time breakdown of Anavex Life Sciences Corp. stock performance2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Micron Tech, Netflix among market cap stock movers on Friday By Investing.com - Investing.com UK
Micron Tech, Netflix among market cap stock movers on Friday - Investing.com
Anavex Life Sciences Crashes as EMA Setback Sparks Doubts on Lead Alzheimer Drug - Investing.com
Anavex Life Sciences Corp. Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease - MarketScreener
Anavex Life Sciences Falls in Premarket Trading After Alzheimer's Drug Receives EU Regulatory Setback - MarketScreener
Anavex Faces CHMP Setback for Alzheimer’s Drug - MSN
Anavex Life Sciences Plans Re-examination Request Following CHMP Feedback and FDA Meeting on Alzheimer's Disease Trial Results - Quiver Quantitative
Anavex (NASDAQ: AVXL) to seek CHMP re-exam; formal opinion expected in December - Stock Titan
Morning Market Movers: CDTX, BCG, IVVD, TSSI See Big Swings - RTTNews
Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug? - Stocktwits
Anavex drops 11% as Martin Shkreli says the pharma is his next short - Seeking Alpha
Ready to Jump After Recent Trade: Anavex Life Sciences Corporation (AVXL) - Setenews
Why Anavex Life Sciences Corp. (12X1) stock could be next leaderMarket Sentiment Review & Comprehensive Market Scan Reports - newser.com
What analysts say about Anavex Life Sciences Corp stockContrarian Investment Ideas & Free Superior Profit Margins - earlytimes.in
Anavex Life Sciences Target of Unusually High Options Trading (NASDAQ:AVXL) - Defense World
Can Anavex Life Sciences Corp. (12X1) stock deliver double digit returns2025 Risk Factors & Real-Time Chart Breakout Alerts - fcp.pa.gov.br
Visual trend scoring systems applied to Anavex Life Sciences Corp.2025 Market Overview & Fast Moving Stock Watchlists - newser.com
Is Anavex Life Sciences Corp. stock supported by strong cash flowsQuarterly Risk Review & Risk Controlled Stock Alerts - fcp.pa.gov.br
Anavex Life Sciences: Inching Closer To Binary Regulatory Outcome In The EU (NASDAQ:AVXL) - Seeking Alpha
Anavex Life Sciences (NASDAQ:AVXL) Share Price Crosses Below Fifty Day Moving AverageShould You Sell? - MarketBeat
Why Anavex Life Sciences Corp. (12X1) stock is favored by hedge fundsJuly 2025 Setups & Verified Chart Pattern Signals - fcp.pa.gov.br
Is Anavex Life Sciences Corp. stock undervalued vs historical averagesJuly 2025 Spike Watch & Verified Swing Trading Watchlist - newser.com
Will Anavex Life Sciences Corp. (12X1) stock top growth indexes2025 Top Gainers & Free Technical Pattern Based Buy Signals - newser.com
D. Boral Capital Reaffirms “Buy” Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from D. Boral Capital - MarketBeat
Anavex Life Sciences (AVXL) Price Target Increased by 28.16% to 44.88 - Nasdaq
AVXL Stock Price and Chart — NASDAQ:AVXL - TradingView
Anavex Life Sciences announces continued long-term benefit from oral blarcamesine in Alzheimer's disease - MarketScreener
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group - markets.businessinsider.com
Anavex Life Sciences Reports Significant Cognitive Benefits of Blarcamesine in Alzheimer's Treatment Compared to Control Group - Quiver Quantitative
Why Is Anavex Life Sciences Stock Trading Higher Today?Anavex Life Sciences (NASDAQ:AVXL) - Benzinga
Anavex (NASDAQ: AVXL) announces 77.4 weeks 'time saved' with blarcamesine over 144 weeks - Stock Titan
Anavex Life Sciences Corporation (AVXL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):